• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医学中的砷剂应用:砷剂的现状和药物递送的最新进展。

Harness arsenic in medicine: current status of arsenicals and recent advances in drug delivery.

机构信息

Jiangsu Key Laboratory of Neuropsychiatric Diseases, Jiangsu Province Engineering Research Center of Precision Diagnostics and Therapeutics Development, and College of Pharmaceutical Sciences, Soochow University, Suzhou, China.

State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, China.

出版信息

Expert Opin Drug Deliv. 2024 Jun;21(6):867-880. doi: 10.1080/17425247.2024.2372363. Epub 2024 Jun 28.

DOI:10.1080/17425247.2024.2372363
PMID:38913024
Abstract

INTRODUCTION

Arsenicals have a special place in the history of human health, acting both as poison and medicine. Having been used to treat a variety of diseases in the past, the success of arsenic trioxide (ATO) in treating acute promyelocytic leukemia (APL) in the last century marked its use as a drug in modern medicine. To expand their role against cancer, there have been clinical uses of arsenicals worldwide and progress in the development of drug delivery for various malignancies, especially solid tumors.

AREAS COVERED

In this review, conducted on Google Scholar [1977-2024], we start with various forms of arsenicals, highlighting the well-known ATO. The mechanism of action of arsenicals in cancer therapy is then overviewed. A summary of the research progress in developing new delivery approaches (e.g. polymers, inorganic frameworks, and biomacromolecules) in recent years is provided, addressing the challenges and opportunities in treating various malignant tumors.

EXPERT OPINION

Reducing toxicity and enhancing therapeutic efficacy are guidelines for designing and developing new arsenicals and drug delivery systems. They have shown potential in the fight against cancer and emerging pathogens. New technologies and strategies can help us harness the potency of arsenicals and make better products.

摘要

简介

砷剂在人类健康史上占有特殊地位,既是毒药又是药物。过去曾用于治疗多种疾病,而三氧化二砷(ATO)在过去一个世纪治疗急性早幼粒细胞白血病(APL)的成功标志着它在现代医学中作为药物的应用。为了扩大其在癌症治疗方面的作用,全世界都在临床应用砷剂,并在开发各种恶性肿瘤,特别是实体瘤的药物输送方面取得了进展。

涵盖领域

在本次检索自 Google Scholar [1977-2024] 的综述中,我们首先介绍了各种形式的砷剂,重点介绍了著名的 ATO。然后概述了砷剂在癌症治疗中的作用机制。本文还提供了近年来开发新的递药方法(如聚合物、无机框架和生物大分子)的研究进展的总结,探讨了治疗各种恶性肿瘤所面临的挑战和机遇。

专家意见

降低毒性和提高治疗效果是设计和开发新的砷剂和药物输送系统的指导原则。它们在对抗癌症和新兴病原体方面显示出了潜力。新技术和策略可以帮助我们利用砷剂的效力,开发出更好的产品。

相似文献

1
Harness arsenic in medicine: current status of arsenicals and recent advances in drug delivery.医学中的砷剂应用:砷剂的现状和药物递送的最新进展。
Expert Opin Drug Deliv. 2024 Jun;21(6):867-880. doi: 10.1080/17425247.2024.2372363. Epub 2024 Jun 28.
2
Acute promyelocytic leukemia: recent advances in therapy and molecular basis of response to arsenic therapies.急性早幼粒细胞白血病:治疗进展及砷剂治疗反应的分子基础
Curr Opin Hematol. 2005 Jan;12(1):1-6. doi: 10.1097/01.moh.0000148552.93303.45.
3
Swallowing a bitter pill-oral arsenic trioxide for acute promyelocytic leukemia.咽下苦口良药——口服三氧化二砷治疗急性早幼粒细胞白血病
Blood Rev. 2016 May;30(3):201-11. doi: 10.1016/j.blre.2015.11.004. Epub 2015 Dec 3.
4
Arsenic trioxide and acute promyelocytic leukemia: clinical and biological.三氧化二砷与急性早幼粒细胞白血病:临床与生物学特性
Curr Top Microbiol Immunol. 2007;313:129-44. doi: 10.1007/978-3-540-34594-7_8.
5
Therapeutic strategy of arsenic trioxide in the fight against cancers and other diseases.三氧化二砷在抗癌及其他疾病治疗策略中的应用。
Metallomics. 2020 Mar 1;12(3):326-336. doi: 10.1039/c9mt00308h. Epub 2020 Mar 12.
6
Balance between the toxicity and anticancer activity of arsenic trioxide in treatment of acute promyelocytic leukemia.三氧化二砷治疗急性早幼粒细胞白血病的毒性与抗癌活性之间的平衡。
Toxicol Appl Pharmacol. 2020 Dec 15;409:115299. doi: 10.1016/j.taap.2020.115299. Epub 2020 Oct 20.
7
Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide.三氧化二砷在急性早幼粒细胞白血病及其他血液系统恶性肿瘤治疗中的进展
Oncologist. 2002;7 Suppl 1:1-13. doi: 10.1634/theoncologist.7-suppl_1-1.
8
Arsenic trioxide as first-line treatment for acute promyelocytic leukemia.三氧化二砷作为急性早幼粒细胞白血病的一线治疗药物。
Am J Health Syst Pharm. 2009 Nov 1;66(21):1913-8. doi: 10.2146/ajhp080342.
9
Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.三氧化二砷单药治疗急性早幼粒细胞白血病患者的红细胞中砷形态的时间进程。
Expert Rev Clin Pharmacol. 2019 Apr;12(4):371-378. doi: 10.1080/17512433.2019.1586532. Epub 2019 Mar 11.
10
Will Arsenic Trioxide Benefit Treatment of Solid Tumor by Nano- Encapsulation?三氧化二砷纳米囊泡给药治疗实体瘤的研究进展
Mini Rev Med Chem. 2020;20(3):239-251. doi: 10.2174/1389557519666191018155426.

引用本文的文献

1
The Potential Use of Arsenic Trioxide in the Treatment of Systemic Lupus Erythematosus.三氧化二砷治疗红斑狼疮的潜力。
Int J Mol Sci. 2024 Sep 4;25(17):9577. doi: 10.3390/ijms25179577.
2
Advanced Application of Polymer Nanocarriers in Delivery of Active Ingredients from Traditional Chinese Medicines.高分子纳米载体在中药活性成分传递中的高级应用。
Molecules. 2024 Jul 26;29(15):3520. doi: 10.3390/molecules29153520.